Reverso Therapeutics
Geneva
About Reverso Therapeutics
Reverso medicines is a biotechnology company that offers therapeutic medicines for anticoagulant therapy.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 1 – 10
- Total funding: $963.7K
- Last round: Grant (Dec 2025)
- Website: reversotherapeutics.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/reverso-therapeutics-24117 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.